FIELD: medicine.
SUBSTANCE: diagnostics of metabolic syndrome includes determination of main symptom: central (abdominal) type of adipositas - waist circumference (WC) is more than 80 cm for women and more than 94 cm for men, as well as additional criteria: hypertension (arterial pressure ≥140/90 mm hg), increase of triglyceride level (≥1.7 gram-mol/l), decrease of high density lipoprotein cholesterol level (<1.0 gram-mol/l for men; <1.2 gram-mol/l for women), increase of low density lipoprotein cholesterol level >3.0 gram-mol/l, fasting hyperglycemia (glucose in the blood plasma on empty stomach ≥6.1 gram-mol/l), glucose tolerance distress (glucose in blood plasma in two hours after glucose loading within the limits of ≥7.8 and ≤11.1 gram-mol/l), obstructive respiration disturbances during sleep. Presence of adipositas and two of above additional criteria is the ground to diagnose metabolic syndrome. Developed and proposed algorithm and criteria of metabolic syndrome diagnostics taking into account all the types of Russian health system will allow increasing metabolic syndrome detection rate among the population. If timely and adequate therapy is provided it will lead to significant reduction of risk associated with development of cardio-vascular complications, diabetes mellitus of type 2 and improvement of patients' life quality.
EFFECT: reduction of risk associated with development of cardio-vascular complications and improvement of patients' life quality.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
DIAGNOSTIC TECHNIQUE FOR METABOLIC SYNDROME IN SCHIZOPHRENIC PATIENTS RECEIVING NEUROLEPTIC THERAPY | 2019 |
|
RU2717367C1 |
METHOD OF DIAGNOSTICS OF METABOLIC SYNDROME BY ULTRASONIC LIPOMETRY | 2017 |
|
RU2677526C1 |
METHOD FOR INDIVIDUAL PREVENTION OF OESTROGEN-DEPENDENT DISEASES AND REPRODUCTIVE DISORDERS IN FEMALES AT AGE OF 18-35 YEARS OLD SUFFERING METABOLIC DISORDERS | 2013 |
|
RU2527358C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS IN PATIENTS WITH METABOLIC SYNDROME | 2003 |
|
RU2264170C2 |
METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
DIET THERAPY FOR CORRECTION OF METABOLIC DISORDERS IN PATIENTS WITH CARDIOVASCULAR DISEASES AND EXCESS BODY WEIGHT | 2018 |
|
RU2661862C1 |
METHOD FOR PREDICTION OF RISK OF METABOLIC SYNDROME | 2013 |
|
RU2530770C1 |
METHOD FOR PREDICTING THE RISK OF DEVELOPING METABOLIC SYNDROME IN YOUNG MALES AGED 18-44 YEARS WHO WORK AT NIGHT | 2021 |
|
RU2778003C1 |
METHOD OF ESTIMATING RISK OF METABOLIC SYNDROME DEVELOPMENT IN CHILDREN BASING ON GENETIC AND BIOCHEMICAL MARKERS | 2012 |
|
RU2492485C1 |
Authors
Dates
2008-10-27—Published
2007-05-30—Filed